Ozempic is a medication used to treat type 2 diabetes. It is a GLP-1 receptor agonist, which means it mimics the action of a hormone called glucagon-like peptide-1 to lower blood sugar levels. [1]

According to drugpatentwatch.com, Ozempic's active ingredient is semaglutide, and it was first approved by the FDA in December 2017. As of May 2021, the drug is still under patent protection and does not have any generic versions available. [1]

However, there are other GLP-1 receptor agonists available on the market that work similarly to Ozempic. According to ro.co, some alternatives to Ozempic include Trulicity, Bydureon, and Victoza. [2]

GoodRx.com provides a comparison chart of GLP-1 receptor agonists, which includes information on their dosages, administration methods, and prices. According to the chart, some other GLP-1 receptor agonists available on the market include Adlyxin, Tanzeum, and Rybelsus. [3]

It is important to note that different medications may work differently for different individuals, and it is best to consult with a healthcare provider to determine the most appropriate treatment option. Additionally, the cost of these medications may vary depending on insurance coverage and other factors. [2][3]

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/OZEMPIC
[2] https://ro.co/health-guide/ozempic-alternatives/
[3] https://www.goodrx.com/classes/glp-1-agonists/glp-1-drugs-comparison